Concepedia

James M. Rhyne

JM

4

Publications

197

Citations

4

H-Index

2005

Active since

Affiliations

Louisville Metabolic and Atherosclerosis Research Center(Current)

Sterling Research Group

James M. Rhyne is an author at Louisville Metabolic and Atherosclerosis Research Center specializing in pharmacotherapy, medicine, and pharmacology.

Top concepts

Publications per year

2005–2010

4

Publications

4

Safety and tolerability of dalcetrapib (RO4607381/JTT-705): results from a 48-week trial

Evan A. Stein, Eli M. Roth, James M. Rhyne et al. · European Heart Journal · 2010 · 107 citations · Full text

Lipid-lowering effects of colesevelam HCl in combination with ezetimibe

Harold Bays, James M. Rhyne, Stacey L. Abby et al. · Current Medical Research and Opinion · 2006 · 58 citations

Year Two Assessment of Fenofibric Acid and Moderate-Dose Statin Combination

Mark Kipnes, Eli M. Roth, James M. Rhyne et al. · Clinical Drug Investigation · 2009 · 20 citations

, , +5

Efficacy and safety profile of fenofibrate-coated microgranules 130 mg, with and without food, in patients with hypertriglyceridemia and the metabolic syndrome: An 8-week, randomized, double-blind, placebo-controlled study

Michael H. Davidson, Harold Bays, James M. Rhyne et al. · Clinical Therapeutics · 2005 · 12 citations

, , +13

Rows per page

1–4 of 4